Literature DB >> 32360093

Diffusion MRI: Technical principles and application to uterine cervical cancer.

L S Fournier1, A-S Bats2, C Durdux3.   

Abstract

Imaging is involved in the management of uterine cervical cancer with several objectives: 1/to assess local and lymph node extension of the initial disease; 2/evaluate treatment response to conservative therapy; 3/detect recurrences. Pelvic MRI is the first-line examination in all these indications. It is the key element for delineation after image fusion when the indication of chemoradiation therapy is made. It is also essential for guiding the placement of applicators and optimising the dosimetry of brachytherapy. The diffusion-weighted acquisition is a sequence sensitive to the motion of water molecules. It allows distinguishing water molecules with free diffusion from water molecules with diffusion restricted by obstacles such as cell membranes or the cytoskeleton. The diffusion is thus connected to the cellularity of the explored tissue, and the cancers, being hypercellular, will present a high signal. It thus provides additional information thanks to a high contrast between the tumour and the surrounding tissues, facilitating detection, evaluation of the volume and extent of the disease.
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Cervix uteri; Chemoradiation; Chimioradiothérapie; Col utérin; Diffusion-weighted imaging; Imagerie; Imaging; Magnetic resonance; Planification; Planning; Pondération diffusion; Résonance magnétique; Traitement; Treatment

Year:  2020        PMID: 32360093     DOI: 10.1016/j.canrad.2020.02.008

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Magnetic resonance imaging in cervical cancer interventional radiotherapy (brachytherapy): a pictorial essay focused on radiologist management.

Authors:  Luca Tagliaferri; Benedetta Gui; Luca Russo; Valentina Lancellotta; Maura Miccò; Bruno Fionda; Giacomo Avesani; Angeles Rovirosa; Piotr Wojcieszek; Giovanni Scambia; Riccardo Manfredi
Journal:  J Contemp Brachytherapy       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.